Clinical Trial Update: Autus Valve Continued Access Study (CAS) [NA]

View source ↗

Summary

Update on the Autus Valve Continued Access Study (CAS) for congenital heart disease; recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Autus Valve

Snippet

Sponsor: Autus Valve Technologies, Inc. | Conditions: Congenital Heart Disease | NA | Status: NOT_YET_RECRUITING